Nu Skin Enterprises Stock Current Valuation

NUS Stock  USD 7.55  0.33  4.57%   
Valuation analysis of Nu Skin Enterprises helps investors to measure Nu Skin's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to gain to 11.06 in 2024. Enterprise Value Multiple is likely to gain to 11.06 in 2024. Fundamental drivers impacting Nu Skin's valuation include:
Price Book
0.5077
Enterprise Value
622.9 M
Enterprise Value Ebitda
79.2805
Price Sales
0.2022
Enterprise Value Revenue
0.3509
Undervalued
Today
7.55
Please note that Nu Skin's price fluctuation is somewhat reliable at this time. Calculation of the real value of Nu Skin Enterprises is based on 3 months time horizon. Increasing Nu Skin's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the NUS stock is determined by what a typical buyer is willing to pay for full or partial control of Nu Skin Enterprises. Since Nu Skin is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NUS Stock. However, Nu Skin's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  7.55 Real  12.09 Target  27.75 Hype  7.16 Naive  6.99
The intrinsic value of Nu Skin's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nu Skin's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
12.09
Real Value
15.36
Upside
Estimating the potential upside or downside of Nu Skin Enterprises helps investors to forecast how NUS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nu Skin more accurately as focusing exclusively on Nu Skin's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.170.180.19
Details
Hype
Prediction
LowEstimatedHigh
3.897.1610.43
Details
Potential
Annual Dividend
LowForecastedHigh
0.520.841.16
Details
3 Analysts
Consensus
LowTarget PriceHigh
25.2527.7530.80
Details

Nu Skin Enterprises Company Current Valuation Analysis

Nu Skin's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Nu Skin Current Valuation

    
  622.91 M  
Most of Nu Skin's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nu Skin Enterprises is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

NUS Current Valuation Driver Correlations

Understanding the fundamental principles of building solid financial models for Nu Skin is extremely important. It helps to project a fair market value of NUS Stock properly, considering its historical fundamentals such as Current Valuation. Since Nu Skin's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nu Skin's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nu Skin's interrelated accounts and indicators.
0.960.220.960.760.620.970.910.160.56-0.19-0.360.440.91-0.540.26-0.80.890.570.76-0.26-0.070.370.290.090.26
0.960.150.910.660.540.870.890.110.46-0.25-0.440.310.87-0.620.26-0.680.910.410.66-0.21-0.090.30.240.130.21
0.220.150.38-0.180.430.26-0.13-0.010.710.140.510.890.310.08-0.38-0.670.440.780.74-0.7-0.640.870.8-0.660.73
0.960.910.380.610.50.940.770.180.64-0.25-0.30.550.93-0.470.08-0.880.850.690.84-0.31-0.140.440.350.10.35
0.760.66-0.180.610.620.790.880.070.27-0.02-0.40.140.53-0.410.64-0.470.550.280.4-0.090.110.140.10.140.08
0.620.540.430.50.620.640.57-0.210.540.340.210.630.47-0.370.37-0.570.740.560.65-0.63-0.410.670.62-0.590.43
0.970.870.260.940.790.640.870.190.61-0.12-0.280.520.9-0.440.25-0.840.820.660.81-0.29-0.050.420.320.060.28
0.910.89-0.130.770.880.570.870.210.26-0.23-0.510.150.78-0.590.48-0.560.760.270.48-0.010.130.10.030.190.03
0.160.11-0.010.180.07-0.210.190.210.06-0.28-0.12-0.070.250.260.08-0.230.09-0.090.150.530.250.01-0.310.190.17
0.560.460.710.640.270.540.610.260.060.340.240.680.50.16-0.06-0.740.60.780.9-0.59-0.460.850.72-0.20.62
-0.19-0.250.14-0.25-0.020.34-0.12-0.23-0.280.340.620.07-0.280.290.090.21-0.040.070.09-0.24-0.240.280.14-0.320.09
-0.36-0.440.51-0.3-0.40.21-0.28-0.51-0.120.240.620.36-0.230.41-0.270.1-0.050.250.18-0.39-0.60.410.3-0.670.44
0.440.310.890.550.140.630.520.15-0.070.680.070.360.51-0.17-0.29-0.810.540.920.81-0.71-0.490.820.79-0.640.62
0.910.870.310.930.530.470.90.780.250.5-0.28-0.230.51-0.5-0.02-0.80.840.620.77-0.25-0.050.30.230.080.2
-0.54-0.620.08-0.47-0.41-0.37-0.44-0.590.260.160.290.41-0.17-0.5-0.070.27-0.51-0.13-0.120.01-0.020.110.050.070.09
0.260.26-0.380.080.640.370.250.480.08-0.060.09-0.27-0.29-0.02-0.070.040.18-0.25-0.060.080.18-0.06-0.160.08-0.04
-0.8-0.68-0.67-0.88-0.47-0.57-0.84-0.56-0.23-0.740.210.1-0.81-0.80.270.04-0.74-0.84-0.910.480.23-0.7-0.610.22-0.53
0.890.910.440.850.550.740.820.760.090.6-0.04-0.050.540.84-0.510.18-0.740.560.81-0.44-0.380.570.47-0.240.47
0.570.410.780.690.280.560.660.27-0.090.780.070.250.920.62-0.13-0.25-0.840.560.88-0.65-0.440.730.71-0.360.56
0.760.660.740.840.40.650.810.480.150.90.090.180.810.77-0.12-0.06-0.910.810.88-0.59-0.450.810.68-0.280.64
-0.26-0.21-0.7-0.31-0.09-0.63-0.29-0.010.53-0.59-0.24-0.39-0.71-0.250.010.080.48-0.44-0.65-0.590.55-0.69-0.870.54-0.41
-0.07-0.09-0.64-0.140.11-0.41-0.050.130.25-0.46-0.24-0.6-0.49-0.05-0.020.180.23-0.38-0.44-0.450.55-0.66-0.650.58-0.81
0.370.30.870.440.140.670.420.10.010.850.280.410.820.30.11-0.06-0.70.570.730.81-0.69-0.660.89-0.640.83
0.290.240.80.350.10.620.320.03-0.310.720.140.30.790.230.05-0.16-0.610.470.710.68-0.87-0.650.89-0.580.67
0.090.13-0.660.10.14-0.590.060.190.19-0.2-0.32-0.67-0.640.080.070.080.22-0.24-0.36-0.280.540.58-0.64-0.58-0.55
0.260.210.730.350.080.430.280.030.170.620.090.440.620.20.09-0.04-0.530.470.560.64-0.41-0.810.830.67-0.55
Click cells to compare fundamentals

NUS Current Valuation Historical Pattern

Today, most investors in Nu Skin Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nu Skin's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Nu Skin current valuation as a starting point in their analysis.
   Nu Skin Current Valuation   
       Timeline  
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Nu Skin Enterprises has a Current Valuation of 622.91 M. This is 96.79% lower than that of the Personal Care Products sector and 98.25% lower than that of the Consumer Staples industry. The current valuation for all United States stocks is 96.25% higher than that of the company.

NUS Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nu Skin's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nu Skin could also be used in its relative valuation, which is a method of valuing Nu Skin by comparing valuation metrics of similar companies.
Nu Skin is currently under evaluation in current valuation category among its peers.

Nu Skin ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Nu Skin's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Nu Skin's managers, analysts, and investors.
Environmental
Governance
Social

NUS Fundamentals

About Nu Skin Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Nu Skin Enterprises's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nu Skin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nu Skin Enterprises based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NUS Stock Analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.